fashion -WSS

fashion

author：knowledge 2025-09-30 22:04:23 - browse：29

FogPharma CEO Mathai Mammen Venrock

SAN FRANCISCO — Six months into his tenure as CEO of cancer startup FogPharma, Mathai Mammen is taking the stage at the Westin St. Francis Tuesday for what he’s calling a “big unveil” of how he’s reshaping the biotech. And he’s prepared to go against the grain.

Perhaps the most important thing he’s telling investors at the J.P. Morgan Healthcare Conference is that he plans to eventually pursue a rare Series E round, rather than an IPO or seeking out acquisition offers.

FogPharma last raised money in November 2022, and will need more cash to bring its lead drug past its ongoing Phase 1/2 trial. Most other biotechs in this position are anxiously eyeing the capital markets, hoping that conditions improve and make an IPO more feasible. But Mammen doesn’t see the point, at this stage. “There’s no reason to be a public company. I don’t know why you’d want to be, really,” he told STAT ahead of FogPharma’s presentation.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： Trump PAC spent more than $40M on legal bills this year as his charges mount: Sources

WSS

Japan raises alarm over China's military, Russia ties and Taiwan tensions in new defense paper

China demands US invite Hong Kong leader to economic meeting, adding to strains over crackdown

What causes rare myocarditis in young men after Covid vaccines?

Sudan conflict brings new atrocities to Darfur as militias kill, rape, burn homes in rampages

Snowpack in the West is melting rapidly. Where will all that extra water go?

Teacher posts viral 'school supply rant' with advice for parents

hotspot

fashion

explore

Tori Bowie and the unacceptable rates of Black maternal death

Biden has enormous polling lead in Democratic primary, despite challenge from RFK Jr.

Trump demands the U.S. pay no more for drugs than other countries … again

The battle over 'scope creep' and who gets to be called 'doctor'

Medicare details structure of new drug price negotiation program

Biden has enormous polling lead in Democratic primary, despite challenge from RFK Jr.

Affirmative action in medical school literally saved lives

Trump team launching legal defense fund to help pay legal bills

Virginia high school admissions case could be legal follow

US economic growth accelerated in 2nd quarter, exceeding expectations and quieting recession fears

entertainment

Sudan conflict brings new atrocities to Darfur as militias kill, rape, burn homes in rampages

9 mass shootings over the weekend rock US cities, leaving 5 dead, 56 injured

Sudan conflict brings new atrocities to Darfur as militias kill, rape, burn homes in rampages

Why patients can’t get everything they want on drug pricing

China demands US invite Hong Kong leader to economic meeting, adding to strains over crackdown

Search called off for baby washed away in Pennsylvania flash flood

Wikipedia

knowledge

focus

leisure time